Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001439222-25-000078
Filing Date
2025-07-10
Accepted
2025-07-10 16:12:22
Documents
3
Period of Report
2025-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1752178329.html 3  
1 FORM 3 wk-form3_1752178329.xml 3 1622
2 EX-24 exhibit241-poaxbackstrom.htm EX-24 4850
3 GRAPHIC exhibit241-poaxbackstrom001.jpg GRAPHIC 290999
  Complete submission text file 0001439222-25-000078.txt   408935
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SCHOLAR ROCK HOLDING CORPORATION 301 BINNEY STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address
Backstrom Jay T. (Reporting) CIK: 0001796398 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 251116457